Mark Schmidt

581 total citations
8 papers, 186 citations indexed

About

Mark Schmidt is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Schmidt has authored 8 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Schmidt's work include Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Prion Diseases and Protein Misfolding (1 paper). Mark Schmidt is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Prion Diseases and Protein Misfolding (1 paper). Mark Schmidt collaborates with scholars based in United States, India and Germany. Mark Schmidt's co-authors include Venkatesh Rajamanickam, Joanna Pucilowska, Brady Bernard, Kayla McCarty, Carmen Ballesteros‐Merino, Carlo Bifulco, Brian Piening, Ephraim Tang, Eric Tran and Christopher Dubay and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Annals of Oncology.

In The Last Decade

Mark Schmidt

8 papers receiving 185 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Schmidt United States	4	125	93	43	31	29	8	186
Tyler G. Searles United States	5	169 1.4×	148 1.6×	53 1.2×	22 0.7×	31 1.1×	7	235
Ivan Práznovec Czechia	3	128 1.0×	150 1.6×	35 0.8×	22 0.7×	24 0.8×	3	209
Guilhem Pupier France	3	136 1.1×	124 1.3×	35 0.8×	15 0.5×	18 0.6×	4	194
Alexander A. Girgis United States	4	111 0.9×	93 1.0×	59 1.4×	24 0.8×	17 0.6×	7	199
Orian Bricard Belgium	5	92 0.7×	92 1.0×	59 1.4×	19 0.6×	29 1.0×	7	182
Elise Ballot France	7	148 1.2×	130 1.4×	61 1.4×	35 1.1×	50 1.7×	10	256
Julia Perkins Smith United States	5	152 1.2×	73 0.8×	87 2.0×	29 0.9×	54 1.9×	12	253
Jolien Ceusters Belgium	7	109 0.9×	161 1.7×	67 1.6×	21 0.7×	17 0.6×	19	248
Caleb Lampenfeld United States	4	176 1.4×	170 1.8×	61 1.4×	39 1.3×	40 1.4×	4	268
Tokiyoshi Tanegashima Japan	6	98 0.8×	82 0.9×	46 1.1×	26 0.8×	43 1.5×	16	163

Countries citing papers authored by Mark Schmidt

Since Specialization

Citations

This map shows the geographic impact of Mark Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Schmidt more than expected).

Fields of papers citing papers by Mark Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Schmidt. The network helps show where Mark Schmidt may publish in the future.

Co-authorship network of co-authors of Mark Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Schmidt. A scholar is included among the top collaborators of Mark Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Schmidt. Mark Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Vita, Alessandro De, Douglas Hanes, Bela Bapat, et al.. (2024). Clinical impact for advanced non-small-cell lung cancer patients tested using comprehensive genomic profiling at a large USA health care system. SHILAP Revista de lepidopterología. 5. 100057–100057. 2 indexed citations

Pucilowska, Joanna, Shu‐Ching Chang, Isaac Kim, et al.. (2022). Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 10(1). e004033–e004033. 11 indexed citations

Gunderson, Andrew J., Venkatesh Rajamanickam, Brady Bernard, et al.. (2021). Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer. OncoImmunology. 10(1). 1900635–1900635. 124 indexed citations

Vrentas, Catherine E., et al.. (2017). Effects of a naturally occurring amino acid substitution in bovine PrP: a model for inherited prion disease in a natural host species. BMC Research Notes. 10(1). 759–759. 2 indexed citations

Bornstein, Sophia, Mark Schmidt, Trevor G. Levin, et al.. (2016). IL-10 and integrin signaling pathways are associated with head and neck cancer progression. BMC Genomics. 17(1). 38–38. 39 indexed citations

Bischoff, Joachim, Jana Barinoff, Christoph Mundhenke, et al.. (2016). A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab pre-treated patients with Her2-positive metastatic breast cancer - E-Vita -. Annals of Oncology. 27. vi85–vi85. 1 indexed citations

English, Isabel A., Jacqueline Martinez, Edward El Rassi, et al.. (2016). Abstract 1631: FGF2 activation of FGFR1 in head and neck squamous cell carcinoma is associated with more invasive disease and can be attenuated by FGFR inhibition. Cancer Research. 76(14_Supplement). 1631–1631. 1 indexed citations

Bornstein, Sophia, Jevgenia Zilberman‐Rudenko, Mark Schmidt, et al.. (2015). Effect of Ionizing Radiation on the Physical Biology of Head and Neck Squamous Cell Carcinoma Cells. Cellular and Molecular Bioengineering. 8(3). 517–525. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact